# Brodalumab

## Lumicef 210mg/1.5mL inj

| 藥物代碼 | ILUMI |
| :--- | :--- |
| 適應症 | Moderate to severe plaque psoriasis, pustular psoriasis. |
| 副作用 | CommonGastrointestinal: Diarrhea \(2.2% \)Immunologic: Infectious disease \(25.4% \), Mycosis \(1.8% to 2.4% \)Musculoskeletal: Arthralgia \(4.7% \)Neurologic: Headache \(4.3% \)Respiratory: Pain in throat \(2.1% \)Other: Fatigue \(2.6% \)SeriousHematologic: Neutropenia, Grade 3 or greater \(0.5% \)Neurologic: Cryptococcal meningitisPsychiatric: Suicidal thoughts, Suicide |
| 禁忌 | Crohn disease, Clinically significant hypersensitivity to brodalumab or any component of the formulation. |
| 藥物保存方式 | 2-8度C |
| 用法用量 | 210 mg at weeks 0, 1, and 2, followed by 210 mg once every 2 weeks. Consider discontinuing if an adequate response is not achieved after 12 to 16 weeks \(continuing treatment beyond 16 weeks in patients without an adequate response is not likely to result in greater success\). |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | [仿單](https://github.com/shin13/formulary-gitbook/tree/94da6e1290882bd3a20ba8b62cd5204e9fbdd50a/toc/im-00-00/im-04-00/節錄/README.md) 沒有孕婦使用的相關風險報告. 已知人類IgG抗體會穿過胎盤屏障,動物實驗中未發現有不良效益 |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | [仿單](https://github.com/shin13/formulary-gitbook/tree/94da6e1290882bd3a20ba8b62cd5204e9fbdd50a/toc/im-00-00/im-04-00/節錄/README.md) 沒有授乳應而或乳汁分泌的影響相關資訊. 動物實驗中發現乳汁中檢測到本藥,請評估受乳嬰兒與母體狀況的風險與利益. |
| 注射劑給藥建議途徑 | SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1.預填充針筒需儲存於2-8度C,勿冷凍. 2.請勿注射於肚臍周圍2吋內. 3.勿揉注射部位 |

